SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients
16 references·0 citing·46 second hop
World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients (2014)World health dilemmas: Orphan and rare di…Universal health coverage: good health, good economics (2012)Universal health coverage: go…Technologies for global health (2012)Technologies for global healthSuicide mortality in India: a nationally representative survey (2012)Suicide mortality in India: a…Grand challenges in global mental health (2011)Grand challenges in global me…Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases (2011)Database identifies FDA-appro…Accelerating access to treatments for rare diseases (2011)Accelerating access to treatm…Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years (2010)Emergence of orphan drugs in …Assessing the Clinical Utility of Diagnostics Used in Drug Therapy (2010)Assessing the Clinical Utilit…Trade, TRIPS, and pharmaceuticals (2009)Trade, TRIPS, and pharmaceuti…Trade and health: an agenda for action (2009)Trade and health: an agenda f…Pharmacoeconomics: NICE's approach to decision‐making (2009)Pharmacoeconomics: NICE's app…Global and regional causes of death (2009)Global and regional causes of…Grand challenges in chronic non-communicable diseases (2007)Grand challenges in chronic n…Global health funding: a glass half full? (2006)Global health funding: a glas…Publication bias in health economic studies. (1997)Publication bias in health ec…Publication Bias in Health Economic Studies (1997)Publication Bias in Health Ec…National Institute for Clinical Excellence and its value judgments (2004)De Testimonio: on the evidence for decisions about the use of therapeutic interventions (2008)Operationalizing Value-Based Pricing of Medicines (2012)Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions (2013)WTP for a QALY and health states: More money for severer health states? (2013)Qualitative Research: Consensus methods for medical and health services research (1995)Principles of Forecasting (2001)The Delphi technique: myths and realities (2003)Global Noncommunicable Diseases — Where Worlds Meet (2010)Tracking global funding for the prevention and control of noncommunicable diseases (2012)Trauma is a public health issue (2017)Risk factors for suicide in China: a national case-control psychological autopsy study (2002)Trends in Suicide Ideation, Plans, Gestures, and Attempts in the United States, 1990-1992 to 2001-2003 (2005)The Burden Attributable to Mental and Substance Use Disorders as Risk Factors for Suicide: Findings from the Global Burden of Disease Study 2010 (2014)Global trends in teenage suicide: 2003–2014 (2015)The global burden of fatal self-poisoning with pesticides 2006-15: Systematic review (2017)Adopting Orphan Drugs — Two Dozen Years of Treating Rare Diseases (2006)Why rare diseases are an important medical and social issue (2008)Orphan drugs: the regulatory environment (2012)The Roles Of Academia, Rare Diseases, And Repurposing In The Development Of The Most Transformative Drugs (2015)Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications (2017)Trade, Growth, and Poverty (2004)Bridging the divide: global governance of trade and health (2009)Trade and social determinants of health (2009)Trade and Public Health: The WTO, Tobacco, Alcohol, and Diet (2011)Trade and investment liberalization and Asia¿s noncommunicable disease epidemic: a synthesis of data and existing literature (2014)Methods for the Economic Evaluation of Health Care Programmes (2005)Fortune at the bottom of the pyramid, the: eradicating poverty through profits (2006)Frugal Innovation in Emerging Markets (2011)Global health 2035: a world converging within a generation (2013)Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory? (2013)Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016)World Health Forum (1981)Defending Interests: Public-Private Partnerships in WTO Litigation (2004)Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia (2007)Advancing health equity in the global marketplace: How human rights can help (2010)Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database Analysis (2012)World Development Report 1990. (1990)Counting the dead and what they died from: an assessment of the global status of cause of death data. (2005)World Population Prospects The 2006 Revision (2007)Declining Autopsy Rates and Suicide Misclassification (2011)Annual Research Review: Mental health and resilience in HIV/AIDS‐affected children – a review of the literature and recommendations for future research (2012)Volunteering by older adults and risk of mortality: A meta-analysis. (2013)Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature (2012)Preventive strategies for mental health (2018)The social determinants of mental health and disorder: evidence, prevention and recommendations (2024)
this work references cited by second hop

References

  • 2011Grand challenges in global mental health2,045 cited
  • 2012Suicide mortality in India: a nationally representative survey938 cited
  • 2007Grand challenges in chronic non-communicable diseases701 cited
  • 2009Global and regional causes of death599 cited
  • 2012Technologies for global health387 cited
  • 2009Trade, TRIPS, and pharmaceuticals175 cited
  • 2009Pharmacoeconomics: NICE's approach to decision‐making152 cited
  • 2010Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years148 cited
  • 2010Assessing the Clinical Utility of Diagnostics Used in Drug Therapy83 cited
  • 2009Trade and health: an agenda for action81 cited
  • 2011Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases71 cited
  • 2012Universal health coverage: good health, good economics70 cited
  • 2011Accelerating access to treatments for rare diseases62 cited
  • 1997Publication bias in health economic studies.34 cited
  • 1997Publication Bias in Health Economic Studies26 cited
  • 2006Global health funding: a glass half full?

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

23 cited

Cited by

No citing works inside the corpus for this window.